Health Alert was shortlisted for The Wearables 2017 Award in the category Digital Health Technology Award.
Health Alert is a joint solution of 112Motion wearable capable of detecting a fall, feature a personal alarm and personalised health analytics from Cardiolyse. The “Alert” products and Health Decision Support platform are key components of the Personal Health System, addressing needs of tomorrow’s patients. This Health Decision Support platform uses Cardiolyse Heart and Emotional Wellness Score algorithms as it’s core.
Cardiolyse has developed proprietary Heart and Emotional Wellness Score algorithms to actively monitor people’s wellbeing.
Cardiolyse is a UK e-healthcare company focused on analytics of human heart electro signals (using both ECG and PPG sensors). With Cardiolyse patented algorithms we extract from 35 to 400 parameters and structure them into Heart Wellness Score. Easy-to-understand for the end user, it can drive behavioural changes, showing a correlation of lifestyle and heart conditions in everyday life.
Using wearables with Cardiolyse Heart and Emotional Wellness Score can engage users in reaching unprecedented levels of healthy behaviour.
Source of the awards information – http://www.wearabletechnologyshow.net
Cardiolyse.me retrospective. 8 months of 2016 results:
ECG (electrocardiogram) processing platform that helps to predict and prevent heart diseases is developed.
– TOP-70 Best European Startups at Pioneers’2016
– TOP-50 Startups investors want to see on Collision Conf’2016
– Selected participant of Silicon Valley Open Door’2016
– Selected participant of Novartis HealthTech Lab at Vivatech’2016
– Winner of Startup.Battle in Ukraine Spring’2016
– Best Ukrainian startup-2016 according to UVCA investors decision.
– Selected participant at TechCrunch SF’2016
Market deployment started – first pilot projects with telemedicine companies in EU.
And more to come!
Cardiolyse.me team is happy to be supported by Isis Innovations, a subsidiary of the University of Oxford.
Isis works with researchers from leading research organizations globally to identify routes and partners for commercialization. It usually works with technologies emerging from the University of Oxford. Therefore, our team was excited to be an exclusion from this rule.
We also work with Isis Innovations in China (Hong Kong) to facilitate international technology transfers. You can find our presentation on Isis Innovations in China. You can find Cardiolyse presentation on Isis Innovations in China.
Cardiolyse welcomes the collaboration with investors and business partners by license or equity investment; that`s why we are glad to cooperate with the research and technology commercialization company of the University of Oxford – Isis Innovations to represent our technology.
Cardiolyse works together with Isis Innovations to promote our new technology of Intelligent ECG!
Cardiolyse was a part of International event as an innovator on 18–19 February 2016 in Katowice. The Congress was held in parallel with the Health Challenges Congress, which attended about 3,000 participants.
The main goal of the Congress was to present investors with the innovators’ potential and facilitate their communication by establishing a regular Forum for exchanging ideas and opinions between investors representing a diverse capital with innovators, inventors, and rationalizers who conduct research and development works in medicine and related areas.
Andrei Karol, the project manager of Cardiolyse Ltd, presented medical technology of smart, thorough and exact ECG. Participants had a chance to discuss the new solutions in e-healthcare that support Active Healthy Ageing in Europe and prevent cardiovascular diseases.
«Doing just one 3 minutes measurement a day we can see the interconnection between such factors of lifestyle as treatment, sports activities, emotional or work stress and heart conditions. The system calculates individual norm of ECG for each person and provides a personalized recommendation for effective cardio care outside of hospitals», – said Andrei.
It is a new generation of ECG solutions. It`s Cardiolyse!